|Mr. David R. Hummel BSc||CEO & Exec. Director||N/A||N/A||59|
|Ms. Louisa S. Burdett BSc Hons, ACA||Group Fin. Director & Exec. Director||395.04k||N/A||N/A|
|Dr. Martin L. Court BSc (Eng), Ph.D.||MD of Invibio Bus., Exec. Director of Medical & Exec. Director||329.04k||N/A||55|
|Mr. Timothy J. Cooper BA Hons||Exec. Director of Industrial, Exec. Director & MD of Victrex Polymer Solutions Bus.||N/A||N/A||N/A|
|Mr. Andrew Hanson||Director of Investor Relations & Communications||N/A||N/A||N/A|
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. It operates through two segments, Victrex Polymer Solutions and Invibio Biomaterial Solutions. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, dental, trauma, knee, cardiovascular, and orthopedic applications. It serves automotive, aerospace, energy, industrial, electronics, and medical markets. The company was incorporated in 1993 and is headquartered in Thornton Cleveleys, the United Kingdom.
Victrex plc’s ISS Governance QualityScore as of September 1, 2017 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 1; Compensation: 5.